Viewing Study NCT03478605

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-02-09 @ 1:18 AM
Study NCT ID: NCT03478605
Status: UNKNOWN
Last Update Posted: 2018-07-05
First Post: 2018-03-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
Sponsor: Blokhin's Russian Cancer Research Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Emesis View
None Vomiting View
None Nausea Post Chemotherapy View
None Nausea View
None Chemotherapy-induced Nausea and Vomiting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None olanzapine View
None aprepitant View
None CINV View
None nausea View
None vomiting View
None nausea and vomiting View
None antiemetics View